Is minimal residual disease in the peripheral-blood stem-cell transplantation of chronic myelogenous leukemia important?
Besa
E C
EC
D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D018365:Neoplasm, Residual